Our core target EGFR had significant positive correlation results in Thymoma, Kidney Chromophobe, Diffuse Large B-Cell Lymphoma, Brain Lower Grade Glioma, and Skin Cutaneous Melanoma. Here, EGFR is linked to diffuse large B-cell lymphoma.